Pardes Biosciences Inc.

NASDAQ: PRDS · Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM

Pardes Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-99.82M 38.49M
Interest Income
n/a n/a
Pretax Income
-96.63M n/a
Net Income
-93.45M -38.55M
Selling & General & Admin
29.47M 10.34M
Research & Development
70.35M 28.15M
Other Expenses
n/a n/a
Operating Expenses
99.82M 38.49M
Interest Expense
3.18M 30K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
99.82M 38.49M
Income Tax Expense
-3.18M 30K
Shares Outstanding (Basic)
58.13M 56.9M
Shares Outstanding (Diluted)
58.13M 56.9M
EPS (Basic)
-1.61 -0.68
EPS (Diluted)
-1.61 -0.68
EBITDA
-93.45M 38.49M
EBIT
-93.45M 38.49M
Depreciation & Amortization
n/a 236.56K